M Volpato
Overview
Explore the profile of M Volpato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rocha A, Monteiro S, Campos I, Volpato M, Verleun D, Valim L, et al.
Braz J Phys Ther
. 2024 Aug;
28(4):101102.
PMID: 39106788
Background: Bladder training (BT), the maintenance of a scheduled voiding regime at gradually adjusted intervals, is a common treatment for overactive bladder (OAB). Objectives: To assess the effects of isolated...
2.
McMahon K, Volpato M, Chi H, Musiwaro P, Poterlowicz K, Peng Y, et al.
J Proteome Res
. 2012 Mar;
11(5):2863-75.
PMID: 22416669
Three dimensional multicell tumor spheroids (MCTS) provide an experimental model where the influence of microenvironmental conditions on protein expression can be determined. Sequential trypsin digestion of HT29 colon carcinoma MCTS...
3.
Hawcroft G, Volpato M, Marston G, Ingram N, Perry S, Cockbain A, et al.
Br J Pharmacol
. 2012 Feb;
166(5):1724-37.
PMID: 22300262
Background And Purpose: The omega-3 polyunsaturated fatty acid (PUFA) eicosapentaenoic acid (EPA) has antineoplastic activity at early stages of colorectal carcinogenesis, relevant to chemoprevention of colorectal cancer (CRC). We tested...
4.
Suggitt M, Fearnley J, Swaine D, Volpato M, Phillips R, Bibby M, et al.
Teratog Carcinog Mutagen
. 2003 Dec;
Suppl 2:13-29.
PMID: 14691977
In order to determine differences in repair after treatment with DNA damaging agents, normal and cancer cells were selected for analysis of single strand breaks and DNA crosslinks using the...
5.
Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R
Ann Endocrinol (Paris)
. 2001 May;
62(2):193-201.
PMID: 11353894
Sera from 300 Italian patients with Addison's disease were collected over a 30 year period. Among these patients, 82% had autoimmune disease, 13% had tuberculosis and 5% had another causal...
6.
Betterle C, Volpato M, Pedini B, Chen S, Smith B, Furmaniak J
J Clin Endocrinol Metab
. 1999 Feb;
84(2):618-22.
PMID: 10022426
Autoimmune Addison's disease and premature ovarian failure are characterized by the presence of organ-specific autoantibodies. The main adrenal and gonadal autoantigens have been identified and cloned, and the relationship between...
7.
Chen S, Sawicka J, Prentice L, Sanders J, Tanaka H, Petersen V, et al.
J Clin Endocrinol Metab
. 1998 Aug;
83(8):2977-86.
PMID: 9709979
A panel of five mouse monoclonal antibodies (MAbs) to human recombinant steroid 21-hydroxylase (21-OH) were produced, characterized, and used to study the interaction of 21-OH autoantibodies (AAbs) with different epitopes...
8.
Betterle C, Greggio N, Volpato M
J Clin Endocrinol Metab
. 1998 Apr;
83(4):1049-55.
PMID: 9543115
No abstract available.
9.
Volpato M, Prentice L, Chen S, Betterle C, Rees Smith B, Furmaniak J
Clin Exp Immunol
. 1998 Mar;
111(2):422-8.
PMID: 9486414
Steroid 21-hydroxylase (21-OH) autoantibodies are found in patients with autoimmune Addison's disease (AAD), either isolated or associated with autoimmune polyglandular syndrome (APS) type I and II and in adrenal-cortex autoantibody...
10.
Betterle C, Volpato M
Eur J Endocrinol
. 1998 Feb;
138(1):16-25.
PMID: 9461309
No abstract available.